217 related articles for article (PubMed ID: 11801669)
1. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.
Compton HL; Farrell JP
J Immunol; 2002 Feb; 168(3):1302-8. PubMed ID: 11801669
[TBL] [Abstract][Full Text] [Related]
2. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
Padigel UM; Perrin PJ; Farrell JP
J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463
[TBL] [Abstract][Full Text] [Related]
3. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
[TBL] [Abstract][Full Text] [Related]
4. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice.
Hazlett LD; McClellan S; Barrett R; Rudner X
J Immunol; 2001 Jan; 166(2):1292-9. PubMed ID: 11145712
[TBL] [Abstract][Full Text] [Related]
5. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
6. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
Courret N; Lang T; Milon G; Antoine JC
Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
[TBL] [Abstract][Full Text] [Related]
7. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
Nishikomori R; Gurunathan S; Nishikomori K; Strober W
J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
[TBL] [Abstract][Full Text] [Related]
8. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
[TBL] [Abstract][Full Text] [Related]
10. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
Lang T; Courret N; Colle JH; Milon G; Antoine JC
Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
[TBL] [Abstract][Full Text] [Related]
11. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
Anderson CF; Mendez S; Sacks DL
J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
[TBL] [Abstract][Full Text] [Related]
12. Human neutrophil-expressed CD28 interacts with macrophage B7 to induce phosphatidylinositol 3-kinase-dependent IFN-gamma secretion and restriction of Leishmania growth.
Venuprasad K; Banerjee PP; Chattopadhyay S; Sharma S; Pal S; Parab PB; Mitra D; Saha B
J Immunol; 2002 Jul; 169(2):920-8. PubMed ID: 12097397
[TBL] [Abstract][Full Text] [Related]
13. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
14. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
Barbi J; Brombacher F; Satoskar AR
J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
[TBL] [Abstract][Full Text] [Related]
15. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
[TBL] [Abstract][Full Text] [Related]
17. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
18. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
Padigel UM; Farrell JP
J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
[TBL] [Abstract][Full Text] [Related]
19. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
Nagase H; Jones KM; Anderson CF; Noben-Trauth N
J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
[TBL] [Abstract][Full Text] [Related]
20. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
